Vol. 4 Issue 4 (2011)

Обложка журнала

PDF downloadDownload the whole Issue

ORIGINAL ARTICLES

Rehabilitation problems of psyche in staff of internal affairs bodies. A.A. Beresnev, V.I. Javornitsky, N.F. Ganoeva P.5

Use of running magnetic field in the combined treatment of patients with chronic prostatitis. I.A. Burenina, V.V. Khasanov P.11

Control of systemic inflammation cellular component by T-regulatory cells in time of exacerbation patients with mild and moderate stage of chronic obstructive pulmonary disease. O.A. Enikeyev, V.I. Nikulicheva, Sh.Z. Zagidullin, S.A. Enikeyeva P.14

Рneumonia and complications during the pandemic influenza A/N1N1/09. I.V. Leshchenko, A.V. Krivonogov P.17

Lung and airways electrical impedance measurement on different probing current frequences or lung functional testing study. V.Ju. Mishlanov P.25

HELP FOR PRACTITIONER

Intracoronary thrombolysis in XXI century: case presentation and literature review. L.V. Tokareva, M.D., E.V. Zhilyaev, E.M. Provalskaya, D.V. Lubimtsev, G.S. Tiber P.29

EXPERIENCE EXCHANGE

Innovations in training general practitioners at the Kazan State Medical University. V.S.Morokov, O.N.Sigitiva, N.B.Amirov P.34

Experience of introduction of system of quality management ISO 9001-2008 in clinical hospital MSCH of the ministry of internal affairs Russian of Republic Tatarstan. L.F. Sabirov, A.V.Spiridonov P.36

LITERATURE REVIEW

Long-acting β2-adrenoceptor agonists — clinical profile and safety. A.A. Vizel, I.Y. Vizel, R.I. Shaymuratov P.39

Neurocardiogenic syncope. A.G. Shcherbakova P.44

CLINICAL LECTURE

Bacterial endocarditis. N.B. Amirov, L.Kh. Safargaliyeva, R.R. Yagfarova P.50

Urticaria and angioedema in family physician practice. A.A. Vasilyeva, R.F. Khakimova P.54

CLINICAL CASE

Primary biliary cirrhosis in male patients. R.G. Sayfutdinov, I.A. Gimaletdinova, Z.M. Galeeva, L.R. Absalyamova, G.G. Faizullina, G.V. Tukhvatullina P.60

JUBILEES

Sayfutdinov R.G. P. 66

CONGRESSES, CONFERENCES

Topical issues of diagnostics, treatment and prophylaxis in general clinic practice. IV All-Russian scientific-practical conference with the participation of doctors of medico-sanitary units of the Ministry of Internal Affairs in the subjects of RF and doctors of Tatarstan Republic, devoted to the 90th anniversary of medical service of system of MIA in Russia, 14—15 October 2011, Kazan. N.B. Amirov, A.A. Vizel, Z.M. Galeyeva, M.V. Potapova P. 68

Brief review of the journal «bulletin of contempo-raryclinical medicine» P. 73

___

ORIGINAL ARTICLES

PDF downloadRehabilitation problems of psyche in staff of internal affairs bodies

A.A. Beresnev, V.I. Javornitsky, N.F. Ganoeva

Abstract. Statistics shows lack of satisfaction, by citizens to quality of medical services, this may be due to today’s medicine is focused on human as material object and at the expense of subjective. So from one side person and his psyche is becoming the reason for development of the disease it may be psychogenic and psychosomatic, from other side not assessable assistant of doctor and patient in getting rid of the disease, with manifestation of interest and activity. In article has been given view (result statistic) which was provided by medical and institutional researchers about the reality of the situation, as well as practical examples of psychotherapy. Although problem is not using the potential of psychotherapy: but fears, suspicions etc hinder the staff of internal affairs on time and properly rehabilitate their health and psyche, eliminating emotional and vegetative strain.

Key words: psychotherapy, psyche, prevention, professional burnout syndrome.

 

References

  1. Arutjunov, A.G. Razrabotka i vnedrenie innovacion¬nyh ozdorovitel'no-reabilitacionnyh tehnologij / A.G. Arutjunov, K.I. Molchanov, P.S. Turzin // Materialy V Mezhdunar. konf. po reabilitologii. — M.: Zlatograf, 2005. — S.6.
  2. Arutjunov, A.G. Perspektivnyj innovacionnyj metod medicinskoj reabilitacii pri psihojemocional'nom stresse / A.G. Arutjunov, T.E. Belousova, V.K. Reshetnjak // Materialy V Mezhdunar. konf. po reabilitologii. — M.: Zlatograf, 2005. — S. 153.
  3. Beresnev, A.A. Karta potenciala lichnosti / A.A. Beresnev // Akadem. zhurn. Zapadnoj Sibiri. — 2006. — № 3. — S.35—36.
  4. Bogomjakov, V.G. Analiz rezul'tatov sociologicheskogo oprosa «Otnoshenie grazhdan k nacional'nym proektam» / V.G. Bogomjakov // Grazhdanskaja tribuna Tjumenskoj ob¬lasti. — Tjumen', 2006. — № 18. — S.2.
  5. Vejn, A.M. Vegetativnye rasstrojstva: klinika, lechenie, diagnostika / A.M. Vejn. — M.: Medicinskoe informaci¬onnoe agentstvo, 2000. — 752 s.
  6. Gogin, E.E. Organy-misheni arterial'nyh gipertonij i stanovlenie gipertonicheskoj bolezni / E.E. Gogin // Kremlevskaja medicina. Klinicheskij vestnik. — 2006. — № 2. — S.10.
  7. Gulevich, Je.A. Algicheskij sindrom kak variant maskiro¬vannoj depressii, ego variabel'nost' i razvitie ipo¬hondricheskogo sindroma u sotrudnikov OVD / Je.A. Gu-levich, L.V. Gulevich // Med. vestnik MVD. — 2006. — № 1(20). — S.27—29.
  8. Dudko, T.L. Arterial'naja gipertenzija (gipertonicheskaja bolezn') / T.L. Dudko // Zabolevanija, javljajushhiesja poka¬zanijami dlja provedenija mediko-psihologicheskoj reabi¬litacii. Centr Upravlenija delami Prezidenta. — M., 2006. — S.5.
  9. Egorova, I.A. Ispol'zovanie metodologii dokaza¬tel'noj mediciny dlja vybora optimal'nyh inno¬vacionnyh metodov v reabilitologii / I.A. Egorova, V.K. Reshetnjak, P.S. Turzin // Materialy V Mezhdunar. konf. po reabilitologii. — M.: Zlatograf, 2005. — S.192—193.
  10. Efimov, A.P. Mediko-social'naja reabilitacija i ee vysshaja cel' / A.P. Efimov // Materialy V Mezhdunar. konf. po reabilitologii. — M.: Zlatograf, 2005. — S.194—195.
  11. Kirjuhin, O.L. Opyt raboty psihologicheskoj sluzhby UVD Rjazanskoj oblasti i Centra prakticheskoj psihologii RGPU im. S.A. Esenina po psihologicheskoj reabilita¬cii detej — zhertv terakta v g. Beslan / O.L. Kirjuhin, A.G. Filichkin [i dr.] // Med. vestnik MVD. — 2006. — № 1(20). — S.23—26.
  12. Metodicheskie rekomendacii. Organizacija mediko-psihologicheskogo obespechenija sotrudnikov organov vnutrennih del Rossijskoj Federacii, vypolnjajushhih zadachi v osobyh uslovijah. — M., 2005. — 47 s.
  13. Mjagkih, N.I. Sovremennye prioritety pri organizacii mediko-psihologicheskogo obespechenija dejatel'nosti or¬ganov vnutrennih del / N.I. Mjagkih, A.V. Kaljaev // Med. vestnik MVD. — 2006. — № 5(24). — S.1—2.
  14. Mjagkih, N.I. Sovremennye metodicheskie podhody k orga¬nizacii mediko-psihologicheskogo obespechenija dejatel'¬nosti organov vnutrennih del / N.I. Mjagkih, A.V. Kaljaev // Med. vestnik MVD. — 2006. — № 6(25). — S.1—3.
  15. Sipko, G.V. Psihosomaticheskie aspekty gipertoniche¬skoj bolezni: znachenie dlja reabilitacii / G.V. Sipko // Kremlevskaja medicina. Klinicheskij vestnik. — 2006. — № 2. — S.61—62.
  16. Subbotina, N.A. Vlijanie posttravmaticheskogo sindroma stressovyh rasstrojstv na razvitie zabolevanij u so¬trudnikov organov vnutrennih del Sverdlovskoj obla¬sti, vernuvshihsja iz komandirovki v Severo-Kavkazskij region / N.A. Subbotina // Med. vestnik MVD. — 2006. — № 1(20). — S.1—2.
  17. Shogenov, A.G. Znachenie sistemnogo kompleksnogo moni¬toringa psihosomaticheskih zabolevanij u sotrudnikov OVD s cel'ju sohranenija professional'nogo dolgoletija / A.G. Shogenov, A.M. Murtazov, A.V. Kravcov // Sovremennye tehnologii vosstanovitel'noj mediciny i reabilitacii. Specializirovannaja med. pomoshh': sb. tr. nauch.-prakt. konf., posvjashh. 80-letiju med. sluzhby GUVD po Sverdl. obl. / pod red. A.V. Limonova [i dr.]. — Ekaterinburg: Izd-vo «Ural», 2009. — S.77—78.
  18. Shogenova, A.B. Arterial'naja gipertonija i faktory riska ateroskleroza u zhenshhin — sotrudnikov pravo¬ohranitel'nyh organov / A.B. Shogenova, A.G. Shogenov A.A. Jel'garov // Aktual'nye voproy razvitija vedom¬stvennoj mediciny MVD Rossii: materialy nauch.-prakt. konf., posvjashh. 75-letiju med. sluzhby GUVD SPb. i Leningradskoj obl. (sent. 2006 g.). — S.355.
  19. Shogenov, A.G. Medicinskie i psihologicheskie aspekty profilaktiki ishemicheskoj bolezni serdca i arterial'¬noj gipertonii sredi sotrudnikov pravoohranitel'nyh organov / A.G. Shogenov A.A. Jel'garov // Aktual'nye vo¬prosy razvitija vedomstvennoj mediciny MVD Rossii: materialy nauch.-prakt. konf., posvjashh. 75-letiju med. sluzhby GUVD SPb. i Leningradskoj obl. (7—9 sent. 2006 g.). — S.354—355.
  20. Shostak, P.G. Psihologicheskie faktory riska razvitija jazvennoj bolezni zheludka i dvenadcatiperstnoj kishki u sotrudnikov organov vnutrennih del / P.G. Shostak, D.A. Sheina, V.N. Klejmenov // Med. vestnik MVD. — 2005. — № 3(16). — S.16—17.

 

PDF downloadUse of running magnetic field in the combined treatment of patients with chronic prostatitis

I.A. Burenina, V.V. Khasanov

 

References

  1. Bogoljubov, V.M. Medicinskaja reabilitacija (rukovod¬stvo): v 3 t. / V.M. Bogoljubov; pod red. V.M. Bogoljubo¬va. — M., 2007.
  2. Gus'kov, A.R. Nasha koncepcija hronicheskogo prostatita / A.R. Gus'kov // Vrachebnoe soslovie. — 2004. — № 5—6. — S.46—50.
  3. Kaprin, A.D. Hronicheskij abakterial'nyj prostatit / A.D. Kaprin, K.N. Milenin, K.V. Ivanenko // Mate¬rialy plenuma pravlenija Rossijskogo obshhestva urologov, 8—10 ijunja 2004 g. — M.; Saratov, 2004. — S.236—237.
  4. Ponomarenko, G.N. Osnovy dokazatel'noj fizioterapii / G.N. Ponomarenko. — SPb.: VMedA, 2003. — 224 s.
  5. Ponomarenko, G.N. Chastnaja fizioterapija: ucheb. posobie / G.N. Ponomarenko; pod red. G.N. Ponomarenko. — M.: OAO «Izd-vo «Medicina», 2005. — 744 s.
  6. Pushkar', D.Ju. Hronicheskij abakterial'nyj prostatit: sovremennoe ponimanie problemy / D.Ju. Pushkar', A.S. Segal // Vrachebnoe soslovie. — 2004. — № 5—6. — S.9—11.
  7. Fizioterapija: nacional'noe rukovodstvo / pod red. G.N. Ponomarenko. — M.: GJeOTAR-Media, 2009.

 

PDF downloadControl of systemic inflammation cellular component by T-regulatory cells in time of exacerbation patients with mild and moderate stage of chronic obstructive pulmonary disease.

O.A. Enikeyev, V.I. Nikulicheva, Sh.Z. Zagidullin, S.A. Enikeyeva

Abstract. Estimate infuence of Tregulatory cells on systemic infammation cellular component in dynamics of exacerbation in patients with mild and moderate stage of chronic obstructive pulmonary disease (COPD). 21 patients participated in research with mild and 21 patient with moderate severity level of COPD. Control group consist from 20 conditionally healthy faces. Signifcant decreasing of Tregulatory cells (CD+4, CD+2 +5) and increasing of T-NK cells (CD+3, CD+1 6, CD+5 6) supervised in both groups in all times of observation. In all patients found leucocytosis and signifcant rise of B-lymphocytes after 10 days of therapy. Conventional therapy of COPD exacerbations in hospital did not affect on restoration of balance between proinfammatory/infammatory cell subpopulations in patients with mild and moderate stage of this disease.

Key words: Т-regulatory cells, chronic obstructive pulmonary disease, systemic infammation, immunology.

References

  1. Avdeev, S.N. Hronicheskaja obstruktivnaja bolezn' leg¬kih: karmannoe rukovodstvo dlja prakticheskih vrachej / S.N. Avdeev. — 2-e izd., pererab. i dop. — M.: Atmosfera, 2010. — S.17.
  2. Allergologija i immunologija: nacional'noe rukovodstvo / pod red. R.M. Haitova, N.I. Il'inoj. — M.: GJeOTAR-Media, 2009. — S.31.
  3. Kost, E.A. Sovetskij gramicidin i ego primenenie v klinicheskoj praktike / E.A. Kost, M.I. Stenko // Nauchnye trudy klinicheskoj bol'nicy im. S.P. Botkina. — M., 1947. — S.253—256.
  4. Leshhenko, I.V. Osnovnye napravlenija lechenija hroni¬cheskoj obstruktivnoj bolezni legkih / I.V. Leshhenko // Terapevticheskij arhiv. — 2007. — № 8. — S.75—84.
  5. Osnovy zakonodatel'stva Rossijskoj Federacii ob ohrane zdorov'ja grazhdan (red. ot 28.09.10) // Vedomosti SND i VS RF. — 1993. — № 33. — St. 1318.
  6. Chuchalin, A.G. Hronicheskie obstruktivnye bolezni legkih / A.G. Chuchalin. — M.: Atmosfera, 1998. — S.11—26.
  7. Shubich, M.G. NBT-test u detej v norme i pri gnojno-bakterial'nyh infekcijah / M.G. Shubich, V.G. Mednikov // Laboratornoe delo. — 1978. — № 9. — S.515—518.
  8. Agusti, A.G.N. Systemic effects of chronic obstructive pulmonary disease / A.G.N. Agusti; eds. D. Chadwick, J.A. Goode // Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment. — Chichester: John Wiley & Sons, Ltd, 2001. — P.242—254.
  9. Agusti, A.G. Systemic effects of chronic obstructive pulmonary disease / A.G. Agusti, A. Noguera, J. Sauleda [et al.] // Eur. Respir. J. — 2003. — Vol. 21(2). — P.347—360.
  10. Feileib, M. Trends in COPD morbidity and mortality in the United States / M. Feileib, H.M. Rosenberg, J.H. Collins [et al.] // Amer. Rev. Respir. Dis. — 1989. — Vol. 140. — P. 9—18.
  11. Gan, W.Q. Association between chronic obstructive pulmonary disease and systemic infammation: a systematic review and a meta-analysis / W.Q. Gan, S.F. Man, A. Senthilselvan [et al.] // Thorax. — 2004. — Vol. 59(7). — P.574—580.
  12. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2010.
  13. Kim, E.Y. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease./ E.Y. Kim, J.T. Battaile, A.C. Patel [et al.] // Nat. Med. — 2008. — Vol. 14(6). — P.633—640.
  14. Leung, B. NKT cells in sepsis. / B. Leung, H.W. Harris // Clin. Dev. Immunol. — 2010. — Vol. 10. — P. 414—650.
  15. Petty, T.L. A new national strategy for COPD / T.L. Petty // J. Respir. Dis. — 1997. — Vol. 18. — P.365—369.
  16. Similowski, T. The potential impact of anaemia of chronic disease in COPD / T. Similowski, A. Agusti, W. MacNee [et al.] // Eur. Respir. J. — 2006. — Vol. 27(2). — P.390—396.
  17. Tkacova, R. Systemic infammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives / R. Tkacova // Mediators Infamm. — 2010. —Vol. 4. — P.585—989.
  18. Wouters, E.F. Systemic effects in COPD / E.F. Wouters, E.C. Creutzberg, A.M. Schols // Chest. — 2002. — Vol. 121 (suppl. 5). — P.127—130.

 

PDF downloadРneumonia and complications during the pandemic influenza A/N1N1/09

I.V. Leshchenko, A.V. Krivonogov

Abstract. Studied the characteristics of the course and complications of community-acquired pneumonia (CAP) for pandemic infuenza A/H1N1/09 based on clinical and laboratory data and radiology. The study involved 250 patients in 4 groups: Group 1 — 57 patients with uncomplicated VP, Group 2 — 124 patients with CAP, and the systemic infammatory response syndrome (SIRS), third group — 53 patients with CAP complicated by severe sepsis, and 4 group — 16 patients with CAP with septic shock. All patients received antiviral, antibacterial and symptomatic therapy, oxygen therapy was carried out by the testimony and artifcial lung ventilation (ALV). In 225 patients (90,0%) have 2-way loss of lung tissue. 193 (77,2%) patients required oxygen therapy, 108 of them (56%) were hospitalized in the intensive care unit and intensive care unit (ICU) (15,6%) carried out artifcial ventilation (mechanical ventilation). Overall mortality was 10,4%, among obese patients — 30,0%.

Key words: community-acquired pneumonia, pandemic infuenza А/Н1N1/09, clinic, complication, treatment.

References

  1. Rai, S. Swine-Origin Infuenza A/H1N1/09: An Update / S. Rai, S. Rane, S. Kumar [et al.]. — Bombay: Hospital Journal, 2009. — Vol. 51(3). — P.331—341.
  2. Bautista, E. Clinical Aspects of Pandemic 2009 Infuenza A/ H1N1/ Virus Infection / E. Bautista, T. Chotpitayasunondh, Z. Gao [et al.] // N. Engl. J. Med. — 2010. — Vol. 362. — P.1708—1719.
  3. Borgatta, B. The 2009 Influenza A/H1N1/ Pandemic-A Blast from the Past / B. Borgatta, J. Rello // US Respiratory Disease. — 2010. — № 6. — P.65—70.
  4. Kliniko-organizacionnoe rukovodstvo. Porjadok okazanija medicinskoj pomoshhi pri infekcii, vyzvannoj pandemi¬cheskim virusom grippa A/H1N1/Kalifornija/04/09, zhite¬ljam Sverdlovskoj oblasti. — Ekaterinburg, 2009.
  5. Bone, R.C. And the ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis / R.C.Bone, R.A. Balk, F.B. Cerra // Chest. — 1992. — Vol. 101. — P.1644—1655.
  6. Bone, R.C. Systemic infammatory response syndrome: a unifying concept of systemic infammation / R.C. Bone, A. Fein, A. Abraham, [et al.] // Sepsis and Multiorgan Failure. — Philadelphia, Pa:. Lippencott, Williams, & Wilkins. — 1997. — P.1—10.
  7. Dellinger, R.P. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock / R.P. Dellinger, M.M. Levy, J.M. Carlet [et al.] // Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 // Intensive Care Med. — 2008. — Vol. 34(1). — P.17—60.
  8. Vnebol'nichnaja pnevmonija u vzroslyh: prakticheskie rekomendacii po diagnostike, lecheniju i profilaktike: posobie dlja vrachej. — M., 2010.
  9. Glanc, S. Mediko-biologicheskaja statistika / S. Glanc. — M.: Praktika, 1999.
  10. WHO Guidelines for Pharmacological Management of Pande¬mic A/H1N1/09 Infuenza and other Infuenza Viruses.

 

PDF downloadLung and airways electrical impedance measurement on different probing current frequences or lung functional testing study

V.Ju. Mishlanov

Abstract. This paper is devoted to clinical results of new lung function diagnostic method estimation. It’s based on electrical impedance of airways and lung parenchyma measurement on different probing electrical current frequencies in the presence of 0,9% sodium chloride solution nebulized inhalation. The theoretical foundation of new diagnostic method is the result showing electrical impedance increasing after local obstruction of the main probing current conductor. Program-apparatus complex «BIA-lab Spiro» was used in present study. Material of study: 10 healthy and 10 asthmatics were examined by classical spirometry technique and new polyfrequent electrical impedance spirometry method. In the group of asthmatics signifcant increasing of electrical impedance module value on 5 000, 10 000 and 20 000 Hz probing electrical current frequencies was revealed. Signifcant correlation links were shown between FEV1, some airfow speed markers and airways electrical impedance module value.

Key words: electrical impedance, spirometry, bronchial asthma.

 

References

  1. Funkcional'naja diagnostika v pul'monologii: prakti¬cheskoe rukovodstvo / pod red. A.G. Chuchalina. — M.: Izdat. holding «Atmosfera», 2009. — 192 s.
  2. Garmash, V.Ja. Pokazateli tetrapoljarnoj reografii v vyjavlenii narushenij gemodinamiki malogo kruga kro¬voobrashhenija / V.Ja. Garmash, A.V. Sokolov, V.N. Zaikin, V.N. Abrosimov // Vrachebnoe delo. — 1987. — № 7. — S.20—22.
  3. Anshhukov. V.K. O sistematizacii pokazatelej reografii legkih / V.K. Anshhukov, Ju.N. Golovcev, E.M. Kucherenko, N.P. Tkachenko // Vrachebnoe delo. — 1987. — № 2. — S.23—25.
  4. Zuev, A.L. Jeksperimental'noe modelirovanie reografi-cheskoj diagnostiki biologicheskih zhidkostej / A.L. Zuev, V.Ju. Mishlanov, A.I. Sudakov, N.V. Shakirov // Rossij¬skij zhurn. biomehaniki. — 2010. — T. 14, № 3(49). — C.68—78.
  5. Gerasimov, A.N. Medicinskaja statistika: ucheb. posobie / A.N. Gerasimov. — M.: OOO «Med. inform. agentstvo», 2007. — 480 s.

 

HELP FOR PRACTITIONER

PDF downloadIntracoronary thrombolysis in XXI century: case presentation and literature review

L.V. Tokareva, M.D., E.V. Zhilyaev, E.M. Provalskaya, D.V. Lubimtsev, G.S. Tiber

Abstract. Clinical case of the male patient 44 years old is presented. In this patient one day after elective coronary stenting acute thrombosis of the stent has developed. Thrombosis was successfully terminated by intracoronary infusion of 30 mg alteplase. Clinical studies of modern using intracoronary thrombolysis (ICT) with concomitant are reviewed. Available data allow us to believe wider usage of ICT in the near future.

Key words: intracoronary thrombolysis, percutaneous coronary interventions, coronary stenting.

 

References

  1. Gurbel, P.A. Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty / P.A. Gurbel, F.I. Navetta, E.R. Bates [et al.] // Cathet. Cardiovasc. Diagn. — 1996. — Vol. 37. — P.382—391.
  2. Hara, M. Predicting no-refow based on angiographic features of lesions in patients with acute myocardial infarction / M. Hara, T. Saikawa, Y. Tsunematsu // J. Atheroscler. Thromb. — 2005. — Vol. 12. — P.315—321.
  3. Kelly, R.V. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase / R.V. Kelly, E. Crouch, H. Krumnacher [et al.] // Catheter. Cardiovasc. Interv. — 2005. — Vol. 66. — P.327—332.
  4. Kim, J.S. Successful revascularization of coronary artery occluded by massive intracoronary thrombi with alteplase and percutaneous coronary intervrention / J.S. Kim, J.H. Kim, H.H. Jang [et al.] // J. Atheroscl. Thromb. — 2010. — Vol. 17. — P.768—770.
  5. Piek, J.J. Beyond Epicardial Reperfusion / J.J. Piek // N. Engl. J. Med. — 2007. — Vol. 356. — P.1880—1882.
  6. Sezer, M. Intracoronary Streptokinase after Primary Percutaneous Coronary Intervention / M. Sezer, H. Ofaz, T. Goren [et al.] // N. Engl. J. Med. — 2007. — Vol. 356. — P.1823—1834.

 

EXPERIENCE EXCHANGE

PDF downloadInnovations in training general practitioners at the Kazan State Medical University

V.S.Morokov, O.N.Sigitiva, N.B.Amirov

Аbstract. Innovational changes in training staff physicians and doctors at the Faculty of General Medical Practice of the Kazan State Medical University for last 17 years are presented.

Key words: general medical practice, training.

 

PDF downloadExperience of introduction of system of quality management ISO 9001-2008 in clinical hospital MSCH of the ministry of internal affairs Russian of Republic Tatarstan

L.F. Sabirov, A.V.Spiridonov

Abstract. In stated article organizational approaches to management of treatment-and-prophylactic establishment with introduction of system of quality management of series ISO 9001 reveal. The importance of management in human potential, ways of planning and the primary goals in work is shown. Realization of main principles of quality management reveals. In clinical hospital of MSU of the Ministry of Internal Affairs of Russia on Republic Tatarstan the quality management system (QMS), corresponding to requirements of standard ISO 9001 versions 2008 is developed, introduced and certifcated. Introduction of system of quality management (QMS) allows to raise considerably productivity and effciency of activity of clinical hospital MSU of the Ministry of Internal Affairs Russian on Republic Tatarstan, quality of given medical services and satisfaction of consumers.

Key words: the personnel, GOST R ISO 9001-2008, strategy, potential, motivation, management, system, the consumer, improvement.

 

References

  1. Bedoreva, I.Ju. Metodologicheskie podhody k obespeche¬niju kachestva medicinskoj pomoshhi na osnove principov mezhdunarodnyh standartov ISO serii 9000 / I.Ju. Be-doreva, N.G. Fomichev, M.A. Sadovoj, V.Ju. Samarina // Problemy upravlenija zdravoohraneniem. — 2005. — № 1. — S.21—26.
  2. Fomichev, N.G. Opyt razrabotki sistemy menedzhmenta kachestva v specializirovannom lechebnom uchrezhdenii / N.G. Fomichev, M.A. Sadovoj, I.Ju. Bedoreva, V.Ju. Sa¬marina // Hirurgija pozvonochnika. — 2005. — № 2. — S.84—88.
  3. Bedoreva, I.Ju. Obespechenie kachestva medicinskoj pomo¬shhi na osnove mezhdunarodnyh standartov ISO serii 9000 / I.Ju. Bedoreva, G.N. Fomichev, M.A. Sadovoj, V.Ju. Sama¬rina // Glavvrach. — 2005. — № 12. — S.36—41.
  4. Bedoreva, I.Ju. Primenenie principov mezhdunarodnyh standartov ISO serii 9000 pri sozdanii sistemy me¬nedzhmenta kachestva v uchrezhdenijah zdravoohranenija / I.Ju. Bedoreva, G.N. Fomichev, M.A. Sadovoj, V.Ju. Samari¬na, N.V. Shajdurova // Obshhestvennoe zdorov'e: innovacii v jekonomike, upravlenii i pravovye voprosy zdravoohra¬nenija: materialy I Mezhdunar. nauch.-prakt. konf., posvjashh. 70-letiju Novosibirskoj gos. med. akademii i 70-letiju kafedry obshhestvennogo zdorov'ja i zdravoohranenija. — Novosibirsk, 2005. — T. II. — S.36—41.
  5. Bedoreva, I.Ju. Rol' principov vseobshhego menedzhmenta kachestva v upravlenii federal'nym uchrezhdeniem zdra¬voohranenija / I.Ju. Bedoreva, N.G. Fomichev, M.A. Sado¬voj, V.Ju. Samarina // Hirurgija pozvonochnika. — 2006. — № 4. — S.75—83.
  6. Sadovoj, M.A. Sistema menedzhmenta kachestva v uchrezhde¬nii zdravoohranenija / M.A. Sadovoj, I.Ju. Bedoreva. — Novosibirsk, 2007. — 320 s.
  7. Bedoreva, I.Ju. Sozdanie jeffektivnogo mehanizma uprav¬lenija uchrezhdeniem zdravoohranenija na osnove sistemy menedzhmenta kachestva / I.Ju. Bedoreva, M.A. Sadovoj // Materialy 9-j Mezhregion. nauch.-prakt. konf. po kachestvu, posvjashh. Vsemirnomu dnju kachestva i Evropejskoj nedele kachestva. — Irkutsk, 2007. — S.66—78.
  8. Sadovoj, M.A. Vnedrenie novyh form upravlenija uchrezh¬deniem zdravoohranenija na osnove sistemy menedzhmenta kachestva / M.A. Sadovoj, I.Ju. Bedoreva // Menedzhment kachestva v sfere zdravoohranenija i social'nogo raz¬vitija. — 2007. — № 2. — S.50—51.
  9. Gulenkov, V.Ju. Novoe v podhode k sertifikacii sis¬tem menedzhmenta kachestva / V.Ju. Gulenkov, M.S. Kup¬rijanova // Standarty i kachestvo. — 2002. — № 3. — S.90—83.
  10. Dvoruk, T.Ju. Udovletvorennost' potrebitelej rossijskih organizacij v zerkale jekspertnyh ocenok / T.Ju. Dvoruk // Sertifikacija. — 2000. — № 3. — S.12—14.
  11. Nikiforov, A.D. Upravlenie kachestvom: ucheb. posobie dlja vuzov / A.D. Nikiforov. — M.: Drofa, 2004 — 720 s.

 

LITERATURE REVIEW

PDF downloadLong-acting β2-adrenoceptor agonists — clinical profile and safety

A.A. Vizel, I.Y. Vizel, R.I. Shaymuratov

Abstract. The safety and clinical profle of inhaled long-acting β2-agonists: a systematic review. Possible mechanisms of long-acting β2-agonists are also described. In addition to existing long-acting β2-agonists (salmeterol and formoterol) we present data about novel β2-agonist — indacaterol with a 24-h duration of action.

Key words: long-acting β2-agonists, safety, salmeterol, formoterol, COPD, bronchial asthma.

 

References

  1. Anderson, G.P. Why are long-acting beta-adrenoceptor agonists long acting? / G.P. Anderson, A. Linden, K.F. Rabe // Eur. Respir. J. — 1994. — Vol. 7, № 3. — P.569—578.
  2. Battram, C. In vitro and in vivo pharmacological characteriza­tion of 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1hquinolin-2-one (indacaterol), a novel inhaled β2 adrenoceptor agonist with a 24-h duration of action / C. Battram, S.J. Charlton, B. Cuenoud [et al.] // J. Pharmacol. Exp. Ther. — 2006. — Vol. 317, № 2. — P.762—770.
  3. West, L.M. Long-acting beta2-adrenoreceptor agonists: salmeterol and formoterol / L.M. West // J. of Malta College of Pharmacy Practice. — 2008. — Vol. 14, № 3. — P.11—14.
  4. Crane, J. Fenoterol and asthma death / J. Crane, N. Pearce, C. Burgess, R. Beasley // N. Z. Med. J. — 1989. — Vol. 102, № 871. — P.356—357.
  5. GINA Report, Global Strategy for Asthma Management and Prevention: Updated 2010. — URL: http://ginasthma.org
  6. Pauwels, R.A. Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial / R.A. Pauwels, M.R. Sears, M. Campbell [et al.] // Eur. Respir. J. — 2003. — Vol. 22, № 5. — P.787—794.
  7. Lцtvall, J. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients / J. Lцtvall, J. Ankerst // Respir. Med. — 2008. — Vol. 102, № 3. — P.449—456.
  8. Walters, E.H. Inhaled long acting beta agonists for stable chronic asthma / E.H. Walters, J.A. Walters, M.D. Gibson // Cochrane Database Syst. Rev. — 2003. — Vol. 4.
  9. WHO Pharmaceuticals Newsletter. Beta-2 agonists — Increased risks of asthma-related deaths. — 2005. — Vol. 4.
  10. Walters, E.H. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid / E.H. Walters, M.D. Gibson, T.J. Lasserson, J.A. Walters // Cochrane Database Syst. Rev. — 2007. — Vol. 1.
  11. Nelson, H.S. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol / H.S. Nelson, S.T. Weiss, E.R. Bleecker [et al.] // Chest. — 2006. — Vol. 129, № 1. — P.15—26.
  12. Glassroth, J. The role of long-acting β-agonists in the management of asthma: analysis, meta-analysis, and more analysis / J. Glassroth // Ann. Intern. Med. — 2006. — Vol. 144, № 12. — P.936—937.
  13. Wolfe, J. Formoterol, 24 microg bid, and serious asthma exacerbations: similar rates compared with formoterol, 12 microg bid, with and without extra doses taken on demand, and placebo / J. Wolfe, C. Laforce, B. Friedman [et al.] // Chest. — 2006. — Vol. 129, № 1. — P.27—38.
  14. Sears, M.R. Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials / M.R. Sears, A. Ottos-son, F. Radner, S. Suissa // Eur. Respir. J. — 2009. — Vol. 33, № 1. — P.21—32
  15. Kemp, J. Safety of formoterol in adults and children with asthma: a meta-analysis / J. Kemp, L. Armstrong, Y. Wan [et al.] // Ann. Allergy Asthma Immunol. — 2011. — Vol. 107, № 1. — P.71—78.
  16. Sears, M.R. Safe use of long-acting β-agonists: what have we learnt? / M.R. Sears // Expert. Opin. Drug Saf. — 2011. — Vol. 10, № 5. — P.767—778.
  17. Donohue, J.F. Safety of indacaterol in the treatment of patients with COPD / J.F. Donohue, D. Singh, O. Kornmann [et al.] // Int. J. Chron. Obstruct. Pulmon. Dis. — 2011. — Vol. 6. — P.477—492.
  18. Pascoe, S. Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD / S. Pascoe, C. Reynolds, W. Pleskow [et al.] // Int. J. Clin. Pharmacol. Ther. — 2011. — Vol. 49, № 2. — P.153—161.
  19. Jones, P.W. Effcacy of indacaterol in the treatment of patients with COPD / P.W. Jones, N. Barnes, C. Vogelmeier [et al.] // Prim. Care Respir. J. — 2011. — Vol. 20. [Epub ahead of print].
  20. Beeh, K.M. Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma / K.M. Beeh, E. Derom, F. Kanniess [et al.]] // Eur. Respir. J. — 2007. — Vol. 29, № 5. — P.871—878.
  21. Worth, H. Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD / H. Worth, K.F. Chung, J.M. Felser [et al.] // Respir. Med. — 2011. — Vol. 105, № 4. — P.571—579.

 

PDF downloadNeurocardiogenic syncope

A.G. Shcherbakova

Abstract. The article presents analysis of diagnosing syncope and different treatment strategies for neurocardiogenic syncope.

Key words: neurocardiogenic syncope, diagnotics, treatment strategies for neurocardiac syncope.

 

References

  1. Gukov, A.O. Nejrokardiogennye (vazovagal'nye) sinkope / A.O. Gukov, A.M. Zhdanov // Russkij med. zhurnal. — 2000. — № 7. — S.34—56.
  2. Dolgih, V.V. Passivnaja ortostaticheskaja proba v dif¬ferencial'noj diagnostike sinkopal'nyh sostojanij / V.V. Dolgih, A.V. Pogodina, O.V. Valjavskaja [i dr.] // Vest¬nik aritmologii. — 2006. — № 43. — S.69—74.
  3. Kardiologija: rukovodstvo dlja vrachej / pod red. R.G. Ogano-va, I.G. Fominoj. — M.: Medicina, 2004. — 848 s.: il.
  4. Miller, O.N. Prichiny sinkopal'nyh sostojanij u lic molodogo vozrasta / O.N. Miller, Z.G. Bondareva, I.A. Gu¬seva // Rossijskij kardiologicheskij zhurnal. — 2003. — № 3. — S.36—43.
  5. Differencial'naja diagnostika obmoroka i jepileptiche¬skogo pripadka / A.V. Pevzner, V.A. Karlov, V.A. Sobolev [i dr.] // Terapevticheskij arhiv. — 2002. — № 4. — S.72—75.
  6. Smetnev, A.S. Sinkopal'nye sostojanija / A.S. Smetnev, N.M. Shevchenko, A.A. Grosu // Kardiologija. — 1988. — № 2. — S.107—110.
  7. Zabolevanija vegetativnoj nervnoj sistemy / pod red. A.M. Vejna. — M.: Medicina, 1991. — 624 s.
  8. Ruksin, V.V. Neotlozhnaja kardiologija / V.V. Ruksin. — SPb.: Nevskij dialekt, 1997. — 471 s.
  9. Grubb, B.P. Tilt table testing; concepts and limitation / V.R. Grubb // PACE. —1997. — Vol. 20, № 1. — P.781— 787.
  10. Day, S.C. Evaluation and outcome of emergency room patient with transient loss of consciousness / S.C. Day, EF. Cook, H. Funkenstein, L. Goldman // Am. J. Med.— 1982. — Vol. 73, № 2. — P.15—23.
  11. Diagnosing syncope. Part 1: Value of history, physical examination and electrocardiography / M. Linzer, E.N. Yang, M. Ester III [et al.] // Ann. Int. Med. — 1991. — Vol. 127, № 3. — P.991.
  12. Paulson, O.B. Cerebral autoregulation / O.V. Paulson, S. Strandgaar, L. Edvinson // Cerebrovasc. Brain. Metab. Rev. — 1990. — № 2. — R.161—192.
  13. Kapoor, W. Evaluation and management of the patient with syncope / W. Kapoor // JAMA. — 1992. — P.2553—2560.
  14. Samoil, D. Vasovagal syncope; Pathophysiology, diagnosis and therapeutic approach / D. Samoil, B.P. Grubb // Eur. J. Pacing Electrophysiology. — 1992. — Vol. 4, № 2. — P.234—241.
  15. Moya, A. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagno¬sis and Management of Syncope of the European Society of Cardiology (ESC) / A. Moya, R. Sutton, F. Ammirati [et al.] // Eur. Heart J. — 2009. — Vol. 30(21). — R.1— Natale, A. Efficacy of different treatment strategies for neurocardiac syncope / A. Natale // PACE. — 1995. — Vol. 18, № 2. — P.655—662.
  16. Ibrahim, M.M. Orthostatic hypotension: mechanism and management / M.M. Ibrahim, R. Tarazi // Am. Heart J. — 1975. — Vol. 90, № 2. — P.513—520.
  17. Reduced susceptibility to syncope during postural tilt in old age. / L.A. Lipsitz, E.R. Mark, J. Koestner [et al.] // Arch. Int. Med. — 1989. — Vol. 149, № 1. — P.2709—2712.
  18. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing / J.S. Sra, A.J. Anderson, S.H. Sheikh [et al.] //Ann. Int. Med. — 1991. — Vol. 114. — P.9—36.

 

CLINICAL LECTURE

PDF downloadBacterial endocarditis

N.B. Amirov, L.Kh. Safargaliyeva, R.R. Yagfarova,

Abstract. This article describes a clinical case of bacterial endocarditis complicated by aorta-mitral valvular disease. Infective endocarditis — infection in the heart valves, endocardium, endothelium of major vessels. The disease is characterized by bacteremia and lesions in various organs and systems.

Key words: bacterial endocarditis, the aortic-mitral defect, heart failure.

 

References

  1. Kovalenko, V.N. Nekoronarogennye bolezni serdca: prak¬ticheskoe rukovodstvo / V.N. Kovalenko, E.G. Nesukaj. — Kiev: Morion, 2001. — 480 s.
  2. Kjemm, Dzh.A. Bolezni serdca i sosudov / A. Dzh. Kjemm, T.F. Ljusher, P.V. Serruis // Rukovodstvo Evropejskogo obshhestva kardiologov. —M.: GJeOTAR-Media, 2011.
  3. Okorokov, A.N. Diagnostika boleznej vnutrennih organov / A.N. Okorokov. — 2001. — 420 s.

 

PDF downloadUrticaria and angioedema in family physician practice

A.A. Vasilyeva, R.F. Khakimova

Abstract. Aetiology, symtoms and principles of therapy the patients with urticaria and angioedema which are the most freaquent diseases in the practice of doctor are shown.

Key words: urticaria, angioedema.

 

References

  1. Allergologija i immunologija: nacional'noe rukovodstvo / pod red. R.M. Haitova, N.I. Il'inoj. — M.: GJeOTAR-Media, 2009. — 656 c.
  2. Immunopatologija i allergologija. Algoritmy diagnostiki i lechenija / pod red. R.M. Haitova. — M.: GJeOTAR-MED, 2003. — 112 s.
  3. Klinicheskaja allergologija detskogo vozrasta s neotlozh¬nymi sostojanijami / pod red. I.I. Balabolkina, V.A. Bul¬gakovoj. — M.: MIA, 2011. — 264 s.
  4. Krapivnica i angiootek: rekomendacii dlja prakticheskih vrachej / pod obshh. red. I.S. Gushhina, N.I. Il'inoj. — M.: FarmarusPrint Media, 2007. — 128 s.
  5. Pampura, A.N. Spektr hronicheskih krapivnic u detej / A.N. Pampura, T.N. Solovej // Sovremennye tehnologii v pediatrii i detskoj hirurgii: materialy VI Rossijskogo kongressa. — M., 2007. — S.43—44.
  6. Safina, L.F. Kozhnye projavlenija allergicheskih reakcij na uzhalenija pereponchatokrylyh nasekomyh / L.F. Sa-fina, R.S. Fassahov, I.D. Reshetnikova // Prakticheskaja medicina. — 2011. — № 3. — S.140—142.
  7. Chastnaja allergologija / pod red. G.B. Fedoseeva. — SPb.: Nordmed-Izdat, 2001. — 464 s.
  8. Bircher, A.J. Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms / A.J. Bircher // Eur. J. Dermatol. — 1999. — Vol. 9. — P.657—663.
  9. Kaplan, A. Chronic urticaria: pathogenesis and treatment / A. Kaplan // J. Allergy Clin. Immunol. — 2004. — Vol. 114. — R.465—474.
  10. Kontou-Fili, K. Clinical advantages of dual activity in urticaria / K. Kontou-Fili // Allergy. — 2000. — Vol. 55 — R.28—33.
  11. Sackesen, C. The etiology of different forms of urticaria in childhood / C. Sackesen, F. Orhan, C. Kosatas [et al.] // Pediatr. Dermatol. — 2004. — Vol. 21. — P.102.
  12. Simons, F. Prevention of acute urticaria in young children with atopic dermatitis / F. Simons // J. Allergy Clin. Immunol. — 2001. — Vol. 107. — R.703—706.
  13. Szczeklik, A. The broken balance in aspirin hypersensitivity / A. Szczeklik, M. Sanak // Eur. J. Pharmacol. — 2006. — Vol. 533. — R.145—155.
  14. Twycross, R. Itch: scratching more than the surface/ R. Twycross, M.W. Greaves, H. Handwerker [et al.] // Q.J. Med. — 2003. — Vol. 96. — R.7—26.
  15. Weidner, C. Acute effects of substance P and calcitonin gene–related peptide in human skin: a microdialysis study / C. Weidner, M. Klede, R. Rukwied [et al.] // J. Invest. Dermatol. — 2000. — Vol. 115. — R.1015—1020.

 

CLINICAL CASE

PDF downloadPrimary biliary cirrhosis in male patients

R.G. Sayfutdinov, I.A. Gimaletdinova, Z.M. Galeeva, L.R. Absalyamova, G.G. Faizullina, G.V. Tukhvatullina

Abstract. This article focuses on the characteristics and clinical diagnosis of primary biliary cirrhosis with a demonstration
of a clinical case of this disease in male patients.

Key words: primary biliary cirrhosis, clinical case, male patient.

 

References

  1. Barzilai, O. Viral infection can induce the production of autoantibodies / O. Barzilai, M. Ram, Y. Shoenfeld // Curr. Opin. Rheumatol. — 2007.
  2. Bogdanos, D.P. Microbial mimics are major targets of cross reactivity with human pyruvate dehydrogense in primary biliary cirrhosis / D.P. Bogdanos, H. Baum, A. Grasso [et al.] // J. Hepatol. — 2004.
  3. Amano, K. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identifcation of antibodies against a common environmental, cosmetic, and food additive, 2 octynoic acid / K. Amano, P.S. Leung, R. Rieger [et al.] // J. Immunol. — 2005.
  4. Rieger, R. Identification of 2 nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis / R. Rieger, P.S. Leung, M.R. Jeddeloh [et al.] // J. Autoimmun. — 2006.
  5. Parikh-Patel, A. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States / A. Parikh-Patel, E.B. Gold, H. Worman [et al.] // Hepatology. — 2001.
  6. Howel, D. An exploratory population-based case-control study of primary biliary cirrhosis / D. Howel, C.M. Fischbacher, R.S. Bhopal [et al.] // Hepatology. — 2000.
  7. Sood, S. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations / S. Sood, P.J. Gow, J.M. Christie, P.W. Angus // Gastroenterology. — 2004.
  8. Bittencourt, P.L. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis / P.L. Bittencourt, A.Q. Farias, C.P. Abrantes-Lemos [et al.] // J. Gastroenterol. Hepatol. — 2004.
  9. Invernizzi, P. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis / P. Invernizzi, P.M. Battezzati, A. Crosignani [et al.] // J. Hepatol. — 2003.
  10. Jones, D.E. Genetic factors in the pathogenesis of primary biliary cirrhosis / D.E. Jones, P.T. Donaldson // Clin. Liver Dis. — 2003.
  11. Springer, J.E. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis / J.E. Springer, D.E. Cole, L.A. Rubin [et al.] // Gastroenterology. — 2000.
  12. Invernizzi, P. Frequency of monosomy X in women with primary biliary cirrhosis / P. Invernizzi, M. Miozzo, P.M. Battezzati [et al.] // Lancet. — 2004.
  13. Miozzo, M. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis / M. Miozzo, C. Selmi, B. Gentilin [et al.] // Hepatology. — 2007.
  14. Podymova, S.D. Bolezni pecheni: rukovodstvo dlja vrachej / S.D. Podymova. — M.: Medicina, 1998.
  15. Reshetnjak, V.I. Mehanizm razvitija vnutripechenochnogo holestaza i lechenie bol'nyh PBC: dis. … d-ra med. nauk / V.I. Reshetnjak. — M., 1996.
  16. Laurin, J.M. The natural history of abdominal pain asso¬ciated with primary biliary cirrhosis / J.M. Laurin, C.K. DeSo-
  17. tel, R.A. Jorgensen [et al.] // Am. J. Gastroenterol. — 1994.
  18. Forton, D.M. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels / D.M. Forton, N. Patel, M. Prince [et al.] // Gut. — 2004.
  19. Poupon, R.E. Quality of life in patients with primary biliary cirrhosis / R.E. Poupon, Y. Chretien, O. Chazouilleres [et al.] // Hepatology. — 2004.
  20. Talwalkar, J.A. Natural history of pruritus in primary biliary cirrhosis / J.A. Talwalkar, R.E. Poupon, Y. Chretien, O. Chazouilleres [et al.] // Clin. Gastroenterol. Hepatol. — 2003.
  21. Majer, K.P. Gepatit i posledstvija gepatita: per. s nem. / K.P. Majer. — M: GJeOTAR-Medicina, 1999.
  22. Ivashkin, V.T. Autoimmunnye zabolevanija pecheni v praktike klinicista / V.T. Ivashkin, A.O. Bueverov. — M.: Vesti, 2001.
  23. Sherlock, S. Diseases of liver and billary system, 10th Blackwell Sci / S. Sherlock, J. Dooley. — Oxford: Publication, 1997.
  24. Lejshner, U. Autoimmunnye zabolevanija pecheni i pere¬krestnyj sindrom / U. Lejshner. — M.: Anaharsis, 2005.

 

JUBILEES

PDF downloadSayfutdinov R.G.

CONGRESSES, CONFERENCES

 

PDF downloadTopical issues of diagnostics, treatment and prophylaxis in general clinic practice. IV All-Russian scientific-practical conference with the participation of doctors of medico-sanitary units of the Ministry of Internal Affairs in the subjects of RF and doctors of Tatarstan Republic, devoted to the 90th anniversary of medical service of system of MIA in Russia, 14—15 October 2011, Kazan

N.B. Amirov, A.A. Vizel, Z.M. Galeyeva, M.V. Potapova

 

PDF downloadBrief review of the journal «bulletin of contempo-raryclinical medicine»